Summary & Overview
HCPCS G9963: Embolization Documentation for Pelvic/Ovarian Arteries
HCPCS Level II code G9963 denotes cases in which embolization endpoints are not documented separately for each embolized vessel or when ovarian artery angiography or embolization is not performed due to variant uterine artery anatomy. As a documentation-oriented code relevant to pelvic arterial embolization, it clarifies procedural limitations that can affect coding and claims adjudication. Nationally, accurate use matters for consistent billing, clinical records, and reimbursement transparency for interventional radiology and gynecologic embolization services.
Key payers included in this overview are Aetna, Blue Cross Blue Shield, Cigna, UnitedHealthcare, and Medicare. Readers will find a concise briefing on the clinical context of the code, common billing scenarios where the code applies, and what to expect in payer coverage discussions. The publication outlines benchmarks and policy-relevant considerations affecting claim acceptance and documentation requirements, and summarizes common modifiers and service-line implications. This national summary is intended for coding professionals, interventional radiology and gynecology billing teams, and revenue cycle managers seeking a focused reference on G9963 and its role in pelvic embolization coding workflows.
Billing Code Overview
HCPCS Level II code G9963 indicates that embolization endpoints are not documented separately for each embolized vessel or that ovarian artery angiography or embolization was not performed in the presence of variant uterine artery anatomy. This code captures documentation limitations or procedure variations during pelvic arterial embolization procedures.
-
Service type: Vascular embolization procedure documentation qualifier
-
Typical site of service: Hospital outpatient department or interventional radiology suite
Clinical & Coding Specifications
Clinical Context
A 38-year-old woman with symptomatic uterine fibroids presents to the interventional radiology suite for uterine artery embolization (UAE) to reduce menorrhagia and bulk symptoms. Pre-procedure pelvic MRI confirms multiple intramural and subserosal fibroids. During angiography, the interventional radiologist documents embolization of the main uterine arteries but does not separately document embolization endpoints for each embolized vessel, and variant uterine artery anatomy is encountered such that ovarian artery angiography or embolization is not performed. The clinical workflow includes pre-procedure consent and imaging review, vascular access (typically common femoral or radial), selective pelvic angiography, embolic particle delivery to occlude uterine arterial blood flow, intra-procedural imaging to assess stasis or endpoint, and post-procedure monitoring in recovery with discharge instructions and outpatient follow-up for symptom assessment and imaging as needed.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | When work or complexity substantially exceeds usual for UAE (extensive anatomy, prolonged fluoroscopy). |
52 | Reduced services |